The clinical research industry is under unprecedented pressure. As older molecules lose patent protection, there is a surge in new therapies queueing to enter the market. Sponsors are demanding faster, more predictable outcomes.

The clinical research industry is under unprecedented pressure. As older molecules lose patent protection, there is a surge in new therapies queueing to enter the market. Sponsors are demanding faster, more predictable outcomes.